T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network
Journal of Hepatology
; 77:S57-S57, 2022.
Article
in English
| Web of Science | ID: covidwho-1980899
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Topics:
Vaccines
/
Variants
Language:
English
Journal:
Journal of Hepatology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS